Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 2
2007 1
2008 4
2009 5
2010 11
2011 5
2012 5
2013 2
2014 4
2015 6
2016 10
2017 7
2018 4
2019 7
2020 7
2021 6
Text availability
Article attribute
Article type
Publication date

Search Results

77 results
Results by year
Filters applied: . Clear all
Page 1
Cabozantinib in patients with platinum-refractory metastatic urothelial carcinoma: an open-label, single-centre, phase 2 trial.
Apolo AB, Nadal R, Tomita Y, Davarpanah NN, Cordes LM, Steinberg SM, Cao L, Parnes HL, Costello R, Merino MJ, Folio LR, Lindenberg L, Raffeld M, Lin J, Lee MJ, Lee S, Alarcon SV, Yuno A, Dawson NA, Allette K, Roy A, De Silva D, Lee MM, Sissung TM, Figg WD, Agarwal PK, Wright JJ, Ning YM, Gulley JL, Dahut WL, Bottaro DP, Trepel JB. Apolo AB, et al. Among authors: sissung tm. Lancet Oncol. 2020 Aug;21(8):1099-1109. doi: 10.1016/S1470-2045(20)30202-3. Epub 2020 Jul 6. Lancet Oncol. 2020. PMID: 32645282 Clinical Trial.
How do you take your coffee?
Sissung TM, Huang PA, Strope JD, Figg WD. Sissung TM, et al. Lancet Oncol. 2019 Jul;20(7):913-914. doi: 10.1016/S1470-2045(19)30387-0. Lancet Oncol. 2019. PMID: 31267961 No abstract available.
Treatment With Carfilzomib-Lenalidomide-Dexamethasone With Lenalidomide Extension in Patients With Smoldering or Newly Diagnosed Multiple Myeloma.
Korde N, Roschewski M, Zingone A, Kwok M, Manasanch EE, Bhutani M, Tageja N, Kazandjian D, Mailankody S, Wu P, Morrison C, Costello R, Zhang Y, Burton D, Mulquin M, Zuchlinski D, Lamping L, Carpenter A, Wall Y, Carter G, Cunningham SC, Gounden V, Sissung TM, Peer C, Maric I, Calvo KR, Braylan R, Yuan C, Stetler-Stevenson M, Arthur DC, Kong KA, Weng L, Faham M, Lindenberg L, Kurdziel K, Choyke P, Steinberg SM, Figg W, Landgren O. Korde N, et al. Among authors: sissung tm. JAMA Oncol. 2015 Sep;1(6):746-54. doi: 10.1001/jamaoncol.2015.2010. JAMA Oncol. 2015. PMID: 26181891 Free PMC article. Clinical Trial.
Insulin potentiation therapy for cancer?
Sissung TM, Schmidt KT, Figg WD. Sissung TM, et al. Lancet Oncol. 2019 Feb;20(2):191-192. doi: 10.1016/S1470-2045(19)30003-8. Lancet Oncol. 2019. PMID: 30712796 No abstract available.
Precision medicine applications in prostate cancer.
McCrea EM, Lee DK, Sissung TM, Figg WD. McCrea EM, et al. Among authors: sissung tm. Ther Adv Med Oncol. 2018 Jun 18;10:1758835918776920. doi: 10.1177/1758835918776920. eCollection 2018. Ther Adv Med Oncol. 2018. PMID: 29977347 Free PMC article. Review.
Stem cell clinics: risk of proliferation.
Sissung TM, Figg WD. Sissung TM, et al. Lancet Oncol. 2020 Feb;21(2):205-206. doi: 10.1016/S1470-2045(19)30787-9. Lancet Oncol. 2020. PMID: 32007195 No abstract available.
Pharmacogenomics and histone deacetylase inhibitors.
Goey AK, Sissung TM, Peer CJ, Figg WD. Goey AK, et al. Among authors: sissung tm. Pharmacogenomics. 2016 Nov;17(16):1807-1815. doi: 10.2217/pgs-2016-0113. Epub 2016 Oct 21. Pharmacogenomics. 2016. PMID: 27767376 Free PMC article. Review.
Pharmacogenomics Implementation at the National Institutes of Health Clinical Center.
Sissung TM, McKeeby JW, Patel J, Lertora JJ, Kumar P, Flegel WA, Adams SD, Eckes EJ, Mickey F, Plona TM, Mellot SD, Baugher RN, Wu X, Soppet DR, Barcus ME, Datta V, Pike KM, DiPatrizio G, Figg WD, Goldspiel BR. Sissung TM, et al. J Clin Pharmacol. 2017 Oct;57 Suppl 10(Suppl 10):S67-S77. doi: 10.1002/jcph.993. J Clin Pharmacol. 2017. PMID: 28921647 Free PMC article. Review.
77 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page